Accumold brings over 30-years’ experience enabling innovation through micro moulding to the MD&M East show in New York, NY, USA 13-15 June 2023, and will be showcasing examples of the impossibly small and intricate parts that it has developed for medical device OEMs on Booth 1044.
The medical device industry is constantly looking for smaller products and components with ever more exacting and often micron-level tolerances. The industry demands absolute precision, totally repeatable manufacturing processes, and zero failure rates for products that are frequently used in safety-critical applications. As such they must work alongside and partner with companies that are working at the cutting-edge of advanced design and manufacture.
Paul Runyan, VP of Sales & Customer Service at Accumold says, “At Accumold, we believe that cost-effective, timely, and innovative products can be manufactured when we work with customers in a truly collaborative manner, and we insist upon transparency at every stage of product development. We have a solutions-oriented focus that when coupled with our unparalleled expertise ensures that we can manufacture end-use medical devices and components others may say are impossible. We are proud to be working at the cutting-edge of medical innovation, and invite all visitors at MD&M East to come and see us, look at the parts that we have made, and we will discuss your specific applications and how Accumold can help realise your product development goals.”
In the area of micro moulding, it is all about heritage. Since 1985, Accumold has been pioneering the art and science of micro moulding, and is rightly today acknowledged as the world leader when it comes to the manufacture of extraordinarily small plastic parts that require extreme precision — typically measured in microns. The company is adept at the production of small-sized parts with micro features from 5 cm to less than 1 mm, and has specific expertise in insert moulding, two-shot moulding, and cleanroom moulding using an array of materials including PEEK, LCP, and most engineering thermoplastics.
The company is unique in that it is truly vertically integrated, and as such it is able to operate as a one-stop partner in the development and manufacture of medical devices and components. Under one roof, Accumold offers design and material assistance, micro tool fabrication, proprietary micro moulding services, cutting-edge metrology, assembly, and automation, and this facilitates the streamlining of customer’s medical product development process, and the attainment of optimal outcomes in terms of timeliness, cost, and accuracy.
Roger Hargens, President at Accumold says, “We are proud to say that we have partnered with countless leading medical device manufacturers across the world, and with each we operate strategically to ensure that the product development process is as efficient as possible. Our over 30-year association with micro moulding and micro manufacturing (and more recently micro additive manufacturing) really gives us the edge, and we are not only the most experienced micro moulder in the world, but also the largest. This affords our customers the reassurance of working with a robust and secure company that can provide efficiencies that lead to affordable pricing, and also one that has the capacity and infrastructure to ramp up to full mass volume manufacture. We are also ISO 13485 accredited, the stringent and internationally recognized quality management system for medical devices.”
Driven by a passionate team of experts with unrivalled experience working at the cutting-edge of medical product innovation, Accumold has a reputation for consistent, repeatable production quality, and the ability to scale volumes from prototypes to millions and even billions of parts. Specifically for the medical device sector, the company works as an enabler, and is able to take on the challenge that many medical product designers have these days, namely finding a product development partner that can make their ever more ambitious, innovative, and complex designs a reality.
Accumold’s team look forward to meeting MD&M show visitors, and discussing the specifics of the medical applications that they have under development.